市场调查报告书
商品编码
1576937
颅内压监测设备:市场洞察·竞争环境·市场预测 (~2030年)Intracranial Pressure Monitoring Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030 |
颅内压监测设备市场规模预计将从 2023 年的 15.5 亿美元增至 2030 年的 24 亿美元,在 2024-2030 年预测期内复合年增长率为 7.60%。
由于多发性硬化症、癫痫和痴呆症等神经系统疾病病例的增加、对这些疾病的认识的提高以及产品开发活动的增加等因素,颅内压监测设备的市场正在显着增长。
颅内压监测设备市场动态:
根据世界卫生组织 (WHO) 2023 年的数据,据报导全球有超过 180 万人受到多发性硬化症 (MS) 的影响。多发性硬化症影响多种功能,包括认知、情绪、运动、感觉和视觉功能。当免疫系统错误地攻击大脑和脊髓时就会发生这种情况。
根据世界卫生组织的数据,到2024年,全球将有约5,000万人受到癫痫的影响,使其成为全球最常见的神经系统疾病之一。近 80% 的癫痫患者生活在低收入和中等收入国家。据估计,如果诊断和治疗得当,70% 的癫痫患者可以无癫痫发作。
相同数据显示,全球有超过 5,500 万人患有失智症,其中 60% 以上生活在低收入和中等收入国家。每年发生近1000万例新病例。
由于多发性硬化症、癫痫和痴呆等神经系统疾病的增加,对颅内压监测设备的需求不断增加。这些情况通常会引起併发症,需要评估颅内压以进行有效管理。颅内压监测装置对于管理多发性硬化症、癫痫发作期间的继发效应以及评估痴呆患者的颅内动态至关重要。
本报告提供全球颅内压监测设备的市场调查,提供市场概要,市场影响因素及市场机会分析,法律制度,市场规模的转变·预测,各种区分·地区/各主要国家的详细分析,竞争情形,主要企业简介等资讯。
Intracranial Pressure Monitoring Devices Market by Technique (Invasive [External Ventricular Drainage (EVD) and Microtransducer ICP Monitoring], and Noninvasive [Transcranial Doppler Ultrasonography, MRI/CT, and Others]), Product Type (Monitors, Probes, Catheters and Kits, and Others), Application (Traumatic Brain Injury, Intracerebral Hemorrhage, Meningitis, and Others), End-User (Hospitals, Homecare, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to advance at a substantial CAGR forecast till 2030 owing to the increasing instances of neurological disorders and the rising product developmental activities across the globe
The intracranial pressure monitoring devices market was valued at USD 1.55 billion in 2023, growing at a CAGR of 7.60% during the forecast period from 2024 to 2030 to reach USD 2.40 billion by 2030. The intracranial pressure monitoring devices market is experiencing significant growth due to the increasing instances of neurological disorders such as multiple sclerosis and epilepsy, and dementia, coupled with increasing awareness of these disorders, and rising product developmental activities that are acting as major factors contributing to the overall growth of the intracranial pressure monitoring devices market during the forecast period from 2024 to 2030.
Intracranial Pressure Monitoring Devices Market Dynamics:
As per data from the World Health Organization (WHO) (2023), it was reported that over 1.8 million people worldwide are affected by Multiple sclerosis (MS). It impacts various functions including cognitive, emotional, motor, sensory, and visual abilities. It occurs when the immune system mistakenly attacks the brain and spinal cord.
Data from the WHO stated that in 2024, around 50 million people worldwide had epilepsy, making it one of the most common neurological diseases globally. Nearly 80% of people with epilepsy live in low- and middle-income countries. It is estimated that up to 70% of people living with epilepsy could have lived seizure-free if they had been properly diagnosed and treated. Additionally, globally, an estimated 5 million people are diagnosed with epilepsy each year. In high-income countries, there were estimated to be 49 per 100,000 people diagnosed with epilepsy each year, whereas in low- and middle-income countries, this figure could be as high as 139 per 100,000.
According to data from the WHO (2023), it stated that more than 55 million people had dementia worldwide, with over 60% living in low- and middle-income countries. Each year, there were nearly 10 million new cases.
Since neurological disorders such as multiple sclerosis, epilepsy, and dementia are growing, there is increasing demand for intracranial pressure monitoring devices. These conditions often lead to complications requiring intracranial pressure assessment for effective management. For instance, intracranial pressure monitoring devices is critical in managing secondary effects in multiple sclerosis, during seizures in epilepsy, and in dementia patients to evaluate intracranial dynamics.
Hence, the interplay of all the above-mentioned factors is expected to drive the intracranial pressure monitoring devices market during the given forecast period from 2024 to 2030.
However, the dearth of skilled specialists for equipment operation and handling, potential risks associated with intracranial pressure monitoring devices, and others may restrict the market growth for the intracranial pressure monitoring devices market.
Intracranial Pressure Monitoring Devices Market Segment Analysis:
Intracranial Pressure Monitoring Devices Market by Technique (Invasive [External Ventricular Drainage (EVD) and Microtransducer ICP Monitoring], and Noninvasive [Transcranial Doppler Ultrasonography, MRI/CT, and Others]), Product Type (Monitors, Probes, Catheters and Kits, and Others), Application (Traumatic Brain Injury, Intracerebral Hemorrhage, Meningitis, and Others), End-User (Hospitals, Homecare, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)
In the technique segment of the intracranial pressure monitoring devices market, the external ventricular drainage (EVD) sub-category of invasive intracranial pressure monitoring devices is expected to have a significant revenue share in the year 2023. This is due to the numerous advantages and applications in intracranial pressure monitoring offered by external ventricular drainage devices.
External ventricular drainage devices offer numerous advantages in managing patients with critical neurological conditions. These devices provide real-time monitoring and therapeutic relief of elevated intracranial pressure by draining cerebrospinal fluid from the ventricles. EVDs also allow precise control over fluid drainage, ensuring that the brain's pressure remains within safe limits, which helps in preventing secondary brain damage.
Additionally, these devices serve as a diagnostic tool by allowing for cerebrospinal sampling, which is essential in identifying infections like meningitis or monitoring for hemorrhagic complications. EVDs are minimally invasive and can be placed in emergency situations, providing immediate therapeutic effects. Their adjustability and precision make them a vital part of neurocritical care, improving both patient outcomes and survival rates when used timely and under appropriate clinical contexts.
Therefore, the widespread uses and various advantages of external ventricular drainage device enhance performance and usability, solidifying a significant impact on the growth of the overall intracranial pressure monitoring devices market during the forecast period from 2024 to 2030.
North America is expected to dominate the overall intracranial pressure monitoring devices market:
Among all the regions, North America is estimated to hold a significant revenue share in the intracranial pressure monitoring devices market. This can be attributed to several factors, including the growing burden of Parkinson's disease, the increasing prevalence of brain injuries caused by trauma, and ongoing product development activities by regulatory authorities supported by the presence of key players in the region that contribute to the growth of the intracranial pressure monitoring devices market in the North America region during the forecast period from 2024 to 2030.
Parkinson's Foundation in 2024 stated that, currently near about one million people in the U.S. are living with Parkinson's disease. This number is projected to increase to 1.2 million by 2030. Parkinson's disease is the second-most common neurodegenerative disorder, following Alzheimer's disease. Each year, approximately 90,000 new cases of Parkinson's are diagnosed in the US. The increasing prevalence of Parkinson's disease is significantly enhancing the market for intracranial pressure monitoring devices. As the number of diagnosed patients rises, there is a growing need for effective management of neurological complications, including those related to elevated intracranial pressure.
According to data provided by the Centre for Disease Control and Prevention (2024), in 2021, there were more than 586 traumatic brain injury-related hospitalizations per day in the US. Traumatic brain injuries, caused by head trauma from accidents, falls, or sports injuries, require prompt and accurate diagnosis to assess the extent of brain damage and guide treatment decisions. The increasing incidence of traumatic brain injuries is driving demand for intracranial pressure monitoring devices, as traumatic brain injuries result in significant hospitalizations, the need for precise and timely intracranial pressure assessment becomes critical for effective management and prevention of secondary brain injury.
Various product developmental strategies such as clearances in the region by regulatory authorities in the region play a major role in pushing forward the revenue shares of intracranial pressure monitoring devices in the region. For example, in August 2024, Aesculap, Inc., in partnership with Christoph Miethke GmbH & Co. KG, announced the U.S. Food and Drug Administration (FDA) approval for Breakthrough Device Designation for the M.scio(R) System. This unique, non-invasive, telemetric pressure measurement system is designed to provide continuous access to long-term, intracranial pressure monitoring of cerebrospinal fluid for the management of hydrocephalus via a permanent, fully implantable sensor.
Moreover, product launches by key market players in the region is further expected to propel the growth of the North America intracranial pressure monitoring devices market.
Therefore, the interplay of all the factors mentioned above would provide a conducive growth environment for the North America region in the intracranial pressure monitoring devices market during the forecast period from 2024 to 2030.
Intracranial Pressure Monitoring Devices Market key players:
Some of the key market players operating in the intracranial pressure monitoring devices market include ArchiMed Group, RAUMEDIC AG, Integra LifeSciences, Sophysa, Spiegelberg GmbH & Co. KG, Medtronic, IRRAS AB, Luciole Medical AG, Saeum Meditec, Recorders & Medicare Systems P Ltd., Shenzhen Delica Medical Equipment Co., Ltd., Viasonix, ELCAT, Atys Medical, RIMED, GE HealthCare., Siemens Healthcare GmbH, Canon Medical Systems Corporation, Hyperfine, Neural Analytics, Inc., and others.
Recent Developmental Activities in the Intracranial Pressure Monitoring Devices Market:
Key takeaways from the Intracranial Pressure Monitoring Devices market report study
Target audience who can be benefited from this Intracranial Pressure Monitoring Devices market report study
Frequently Asked Questions for the Intracranial Pressure Monitoring Devices Market:
Among all the regions, North America is estimated to hold a significant revenue share in the intracranial pressure monitoring devices market. This can be attributed to several factors, including the growing burden of Parkinson's disease, the increasing prevalence of brain injuries caused by trauma, and ongoing product development activities by regulatory authorities supported by the presence of key players in the region that contribute to the growth of the intracranial pressure monitoring devices market in the North America region during the forecast period from 2024 to 2030.